Erasca, Inc. - Common Stock (NQ:ERAS)

14.39 +0.35 (+2.49%)

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Erasca, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700% ↗

May 14, 2026

This clinical-stage biotech develops targeted therapies for RAS/MAPK pathway-driven cancers, addressing hard-to-treat tumor types.

Via The Motley Fool

Topics Regulatory Compliance

ERASCA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

May 12, 2026

From Kirby McInerney LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

May 12, 2026

From Pomerantz LLP

Via GlobeNewswire

Erasca (NASDAQ:ERAS) Beats Q1 Estimates on Promising ERAS-0015 Data ↗

May 11, 2026

Via Chartmill

ERAS Stock Earnings: Erasca Misses EPS for Q2 2024 ↗

August 12, 2024

ERAS stock results show that Erasca missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

ERAS Investors Have Opportunity to Join Erasca, Inc. Fraud Investigation with the Schall Law Firm

May 10, 2026

From Schall Law

Via GlobeNewswire

Stock Market Today, April 28: Erasca Plunges After Patient Death in Early Cancer Drug Trial ↗

April 28, 2026

Today, April 28, 2026, investors are weighing how a trial death will reshape Erasca's investment thesis.

Via The Motley Fool

Topics Stocks

Here are the top movers in Tuesday's session. ↗

April 28, 2026

Via Chartmill

Which stocks are experiencing notable movement on Tuesday? ↗

April 28, 2026

Via Chartmill

Gapping stocks in Tuesday's session ↗

April 28, 2026

Via Chartmill

Top movers in Tuesday's pre-market session ↗

April 28, 2026

Via Chartmill

What's going on in today's after hours session ↗

April 27, 2026

Via Chartmill

Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't ↗

March 26, 2026

This oncology biotech, developing targeted cancer therapies, reported a notable insider sale following a remarkable year for its stock.

Via The Motley Fool

Topics Regulatory Compliance

Registration Momentum Builds Across the Oncology Pipeline

February 17, 2026

Issued on behalf of Oncolytics Biotech Inc.

From USA News Group

Via GlobeNewswire

Erasca (ERAS) Stock Slides After The Bell: Here's Why ↗

January 20, 2026

Erasca Inc (NASDAQ:ERAS) shares are moving lower in extended trading Tuesday after the company announced a proposed public offering.

Via Benzinga

Erasca Insider Sells $671K as Stock Jumps 189% This Past Year ↗

January 13, 2026

This oncology biotech developing targeted cancer therapies saw a key insider significantly trim their direct equity stake.

Via The Motley Fool

Topics Regulatory Compliance

Get insights into the top gainers and losers of Thursday's after-hours session. ↗

January 08, 2026

Via Chartmill

The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader

January 08, 2026

The first week of 2026 has set the biotech sector ablaze, with Revolution Medicines (NASDAQ: RVMD) finding itself at the epicenter of a high-stakes acquisition tug-of-war. Shares of the Redwood...

Via MarketMinute

Topics Intellectual Property

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

January 08, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

January 07, 2026

Via Chartmill

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B

November 19, 2025

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:ALXO),(NASDAQ:ERAS),(NASDAQ:IMRX),(NASDAQ:PRLD) EQNX::TICKER_END

Via FinancialNewsMedia

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B

November 19, 2025

From FN Media Group LLC

Via GlobeNewswire

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 02, 2025

Via Benzinga

Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket ↗

October 02, 2025

Via Benzinga

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

September 03, 2025

Via Benzinga

Erasca Narrows Loss 46% in Fiscal Q2 ↗

August 12, 2025

Via The Motley Fool

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday ↗

April 21, 2025

Via Benzinga

This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

March 26, 2025

Via Benzinga

Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

December 02, 2024

Via Benzinga

e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday ↗

May 23, 2024

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.